We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.21%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.44B
AUM Growth
+$25.6M
Cap. Flow
+$82.4M
Cap. Flow %
1.51%
Top 10 Hldgs %
19.14%
Holding
760
New
155
Increased
313
Reduced
140
Closed
45

Top Sells

Rank Stock Value
1
LKQ icon
LKQ Corp
LKQ
+$54.6M
2
LNKD
LinkedIn Corporation
LNKD
+$51.3M
3
AMZN icon
Amazon
AMZN
+$40.3M
4
LO
LORILLARD INC COM STK
LO
+$39.9M
5
CPA icon
Copa Holdings
CPA
+$38.9M

Sector Composition

Rank Sector Weight
1 Financials 17.2%
2 Consumer Discretionary 15.8%
3 Industrials 13.42%
4 Technology 13.22%
5 Healthcare 11.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKTX icon
51
MarketAxess Holdings
MKTX
$5.72B
$45.7M 0.84%
772,389
+35,822
+5% +$2.21M
CBOE icon
52
Cboe Global Markets
CBOE
$32.8B
$44.6M 0.82%
788,098
-98,932
-11% -$5.31M
META icon
53
Meta Platforms (Facebook)
META
$1.45T
$44.3M 0.81%
735,407
+664,407
+936% +$42.1M
DOV icon
54
Dover
DOV
$27.2B
$43.2M 0.79%
654,921
-121,090
-16% -$7.53M
AMG icon
55
Affiliated Managers Group
AMG
$9.58B
$42M 0.77%
210,051
-356
-0.2% -$69.9K
LNKD
56
DELISTED
LinkedIn Corporation
LNKD
$41.7M 0.77%
225,500
-250,297
-53% -$51.3M
CTRA
57
DELISTED
Coterra Energy
CTRA
$37.2M 0.68%
1,097,692
-965,193
-47% -$35.6M
ELV icon
58
Elevance Health
ELV
$86.6B
$36.9M 0.68%
371,130
+6,077
+2% +$550K
PII icon
59
Polaris
PII
$3.63B
$36.7M 0.67%
262,821
+30,168
+13% +$4.07M
MON
60
DELISTED
Monsanto Co
MON
$34.4M 0.63%
302,406
+168,429
+126% +$18.7M
SLXP
61
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$33.6M 0.62%
324,479
+305,017
+1,567% +$31.2M
FRC
62
DELISTED
First Republic Bank
FRC
$32.8M 0.6%
606,707
+246,390
+68% +$12.7M
ROK icon
63
Rockwell Automation
ROK
$48.1B
$32.4M 0.59%
259,829
+68,544
+36% +$8.14M
ECL icon
64
Ecolab
ECL
$80.1B
$32.3M 0.59%
299,212
-14,241
-5% -$1.49M
GPC icon
65
Genuine Parts
GPC
$18.8B
$31.4M 0.58%
361,113
+3,459
+1% +$292K
BN icon
66
Brookfield
BN
$92.5B
$30.3M 0.56%
3,169,459
+37,387
+1% +$341K
DNKN
67
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$30.3M 0.56%
603,365
+3,820
+0.6% +$188K
JNJ icon
68
Johnson & Johnson
JNJ
$640B
$29.9M 0.55%
303,876
+241,309
+386% +$22.4M
MANH icon
69
Manhattan Associates
MANH
$13B
$28.2M 0.52%
804,262
+754,326
+1,511% +$26.3M
YELP icon
70
Yelp
YELP
$1.22B
$27.5M 0.51%
357,508
+146,910
+70% +$12.4M
MEOH icon
71
Methanex
MEOH
$4.51B
$26.7M 0.49%
+417,711
New +$26.4M
AMGN icon
72
Amgen
AMGN
$236B
$25.4M 0.47%
205,975
+203,730
+9,075% +$24.7M
USB icon
73
US Bancorp
USB
$97.2B
$24.1M 0.44%
561,755
+9,844
+2% +$405K
PODD icon
74
Insulet
PODD
$9.95B
$23.5M 0.43%
494,714
+486,549
+5,959% +$21.5M
CLB icon
75
Core Laboratories
CLB
$564M
$22.5M 0.41%
113,163
+36,231
+47% +$6.84M

Similar funds

Geneva Advisors's Q1 2014 Portfolio in Review

As of Q1 2014, Geneva Advisors held 760 positions worth $5.44B, up 0.47% from $5.42B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneva Advisors's Q1 2014 filing shows 155 new, 313 increased, 140 reduced and 45 closed positions. Its largest new stake was Methanex: 417,711 shares worth $26.7M. The largest sale was LKQ Corp, an estimated $54.6M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Geneva Advisors's largest Q1 2014 buy was Methanex: 417,711 shares worth $26.7M.
  • Geneva Advisors added most to JPMorgan Chase in Q1 2014, an estimated $51.9M increase.
  • Geneva Advisors's biggest Q1 2014 reduction was LKQ Corp, cutting an estimated $54.6M.
  • Geneva Advisors fully exited QIWI PLC in Q1 2014, selling an estimated $26.1M.
  • Geneva Advisors's ten largest holdings make up 19% of its $5.44B portfolio in Q1 2014.
  • Geneva Advisors opened 155 new positions and closed 45 in Q1 2014.
  • Geneva Advisors's portfolio value rose 0.47% quarter-over-quarter to $5.44B.

Based on Geneva Advisors's 13F filing for Q1 2014, filed 5 May 2014.